Literature DB >> 16420068

Synthesis and in vitro antitumor activity of platinum acetonimine complexes.

Angelina Boccarelli1, Francesco P Intini, Rossella Sasanelli, Maria F Sivo, Mauro Coluccia, Giovanni Natile.   

Abstract

The cis- and trans-dichloro- and diiodo-platinum(II) complexes containing two acetonimines (cis- and trans-[PtX(2){HN=C(CH(3))(2)}(2)], 1 and 2 for X = Cl and 1' and 2' for X = I, respectively) or one acetonimine and one ammine (cis- and trans-[PtX(2)(NH(3)){HN=C(CH(3))(2)}], 3 and 4 for X = Cl and 3' and 4' for X = I, respectively) have been prepared from platinum-ammine precursors by condensation with acetone. Except for the cis-diiodo species, in all other cases the presence of a base was required. A crucial role of the ligand trans to the ammine undergoing condensation with acetone has been disclosed: the greater the trans effect the greater the reactivity. In a panel of human tumor cell lines representative of ovarian, colon, lung, and breast cancers, cis complexes 1 and 3 are less active than cis-DDP (mean IC(50) = 20, 12.5, and 2.8 microM, respectively), whereas trans complexes 2 and 4 are more active than trans-DDP (mean IC(50) = 10.6, 26, and 164 microM, respectively), thus indicating that substitution of acetonimine for one or two ammine ligands determines strikingly different effects depending upon the complex geometry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420068     DOI: 10.1021/jm050986t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

2.  Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.

Authors:  Marilù Sinisi; Valentina Gandin; Teresa Saltarella; Francesco P Intini; Concetta Pacifico; Christine Marzano; Giovanni Natile
Journal:  J Biol Inorg Chem       Date:  2014-05-22       Impact factor: 3.358

Review 3.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

4.  Solution behaviour and biological activity of bisamidine complexes of platinum(II).

Authors:  C Marzano; S Mazzega Sbovata; F Bettio; R A Michelin; R Seraglia; T Kiss; A Venzo; R Bertani
Journal:  J Biol Inorg Chem       Date:  2007-01-09       Impact factor: 3.862

5.  Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds?

Authors:  Eva Corral; Anna C G Hotze; Hans den Dulk; Anna Leczkowska; Alison Rodger; Michael J Hannon; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2008-12-16       Impact factor: 3.358

6.  Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions.

Authors:  Anton A Legin; Michael A Jakupec; Nadezhda A Bokach; Marina R Tyan; Vadim Yu Kukushkin; Bernhard K Keppler
Journal:  J Inorg Biochem       Date:  2013-12-22       Impact factor: 4.155

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.